Small Molecule Screening

PrimePath is a drug discovery service from BioFocus DPI that allows small molecules to be screened in biological assays using disease-relevant human primary cells. This service combines proven screening capabilities with expertise in human primary cell models of disease. PrimePath is BioFocus DPIs response to the need for screening systems that take account of the complexity of biological control and feedback mechanisms in key cell types that underlie disease processes.